Colorectal cancer is less common in the Middle East and South Asia than in western countries, with the rectum the most common primary site, unlike in the United States. A project was planned to address various local issues regarding the management of common cancers, including colorectal cancer, and to adapt the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) to the Middle East and North Africa (MENA) region. A survey of oncologists in this geographic area showed that the management practices and issues regarding colorectal cancer are similar to those presented in the NCCN Colorectal Cancer Guidelines. However, 2 major differences exist: most oncologists in the MENA region prefer chest radiograph over CT in pretreatment workup, and almost 50% of
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In a study from Turkey, one third of patients were younger than 50 years, and the rectum was the most common site of occurrence (42.5%), followed by the sigmoid colon (23.2%). 2 The epidemiologic features are similar in India. 3 However, in a study from Qatar, the descending and sigmoid colon were the most common sites. 4 Although the management of colorectal cancer should ideally be based on evidence-based medicine, standardized practices do not exist in other parts of the world. The social, cultural, and economic differences among the countries may be responsible for this lack of standard management. The paucity of local randomized trials from the Committee members met on March 8, 2009 , in Istanbul to discuss the survey results and other issues, including proposals for adapting the NCCN guidelines to the MENA region. The proposals accepted by the majority were prepared for presentation at a congress in the United Arab Emirates.
Proposed Modifications Proposal 1
Short-course preoperative radiotherapy (SCRT) may be an alternative for long-course preoperative radiotherapy (LCRT) or chemoradiotherapy in operable rectal cancer with smaller tumors (< T4).
Rationale
Preoperative SCRT was found to reduce the local recurrence in rectal cancer when compared with surgery alone. 5 In a large randomized trial, the Dutch Colorectal Cancer Group showed a significant reduction of local recurrence risk with SCRT followed by total mesorectal excision (TME) compared with TME alone. 6 Significant improvement was observed for rectal lesions 5 cm or smaller and those larger than 5 cm.
Another small randomized study from Bulgaria suggests that although SCRT is less effective than conventional radiotherapy in reducing local tumor recurrences in the lower third of the rectum and for advanced rectal cancer (T4 and N2), it is equally as effective in treating other occurrences. 7 A Polish study comparing preoperative SCRT with chemoradiation showed similar survival, local control, and late toxicity for both treatments at 4 years. 8 Another review of the 2 randomized trials on 396 patients showed that SCRT may be as effective as conventional radiotherapy/chemoradiation. 9 A recent retrospective analysis of clinical outcome in 520 Danish patients with rectal cancer also confirmed the efficacy of SCRT. 10 Furthermore, a survival benefit was observed for SCRT in the Swedish Rectal Cancer Trial.
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In conclusion, the evidence favors preoperative SCRT as an alternative to conventional preoperative radiotherapy/chemoradiation in operable rectal cancer.
Proposal 2
Dose of capecitabine may be lower than 1000 mg/m 2 twice daily. region adds to the difficulty in following new developments and innovations. However, the need for guidelines that are compatible with evidence-based medicine and social, cultural, and economic realities of the MENA region cannot be denied. The NCCN-MENA project was established to address this need.
Methods and Results
The colorectal cancer committee comprised 9 members from 6 different countries who collected the data and participated in the deliberations. A survey with 11 questions related to the management of colorectal cancer was prepared and sent to all members to determine the patterns of care and compatibility with the 2009 version of the NCCN Clinical Practice Guidelines in Oncology: Colorectal Cancer (to view the most recent version of these guidelines, visit the NCCN Web site at www.NCCN.org). The survey was distributed to 24 well-known gastrointestinal oncologists in Turkey, and personal opinions were obtained from members in Qatar, United Arab Emirates, and India; Table 2 summarizes the results. Answers from most oncologists in Turkey and committee members from other countries were generally in accordance with the NCCN Guidelines, except those related to questions number 1 and 10. According to the results, 69% did not perform routine chest CT before surgery for all patients with colon cancer. With regard to first-line chemotherapy for metastatic colorectal cancer, 47% of those surveyed preferred to use cetuximab in addition to chemother- Data from Borchana et al. 5 Many patients in this region are unable to tolerate recommended higher dosages because of severe hand-foot syndrome or diarrhea (based on personal experience of the committee). This could be related to high folate intake in the diet or issues related to food hygiene. The committee proposed a prospective trial be conducted to find the optimal dose for the patients in the region.
Proposal 3
Stereotactic radiation for liver metastasis could be an alternative.
Rationale
Resection is the standard of care for treating liver metastasis in colorectal cancer. However, more than 80% of patients have unresectable disease. Several studies have shown the efficacy of stereotactic body radiation therapy as an alternative to radiofrequency ablation in treating this condition. [12] [13] [14] [15] A phase I/ II study showed that it is also safe and effective for treating grade 1 to 3 metastasis. 16 
Proposal 4
Operations should be performed by surgeons experienced in colorectal surgery and TME, and the surgeries should occur at centers conducting more than 50 surgeries per year.
Rationale
The surgeon is an independent factor for outcome in colorectal surgery. The outcome was also related to surgical caseload and training/teaching activities. 17 Because of the lower incidence of colorectal cancer, a dilution of cases between centers occurs in some countries. Some patients managed by general surgeons are found to lack TME for rectal cancer or adequate lymph node dissection. Although no specific caseload number has been established for surgeons, 
Conclusions
This multinational project is the first in the region with the goal of establishing standard management of colorectal cancer. The recommendations are based on evidence in the literature and personal experiences that must be tested in prospective randomized studies. Continuation of this scientific cooperation between NCCN and the MENA countries may improve quality of care for patients with colorectal cancer in the region.
